Eric Jordie, M.S.

Vice President of TSP, Quantitative Sciences

Aside from his first seven years modeling planetary and biological systems at NASA, Eric’s twenty-year career has focused on the strategic application of advanced analytics, modeling, and simulation techniques to interpret and integrate biopharmaceutical data and to quantitatively inform pre-clinical through late phase clinical drug development decision making. In particular, Eric has extensive industrial experience developing and applying a broad continuum of translational, pharmacometric, and systems pharmacology techniques and strategies across diverse therapeutic areas. Eric is especially passionate about collaborations focused on developing and implementing quantitative frameworks used to advance the development of immunotherapeutics.

Recent publications by this scientist

Bayesian PBPK Modeling using R/Stan/Torsten and Julia/SciML/Turing.jl

October 28, 2022

Ahmed Elmokadem, Yi Zhang, Tim Knab, Eric Jordie, William R. Gillespie. Poster presented at 2022 American Conference on Pharmacometrics (ACoP13). 30 October – November 2 2022. Poster W-074

Download PDF

Landscape analysis for a neonatal disease progression model of bronchopulmonary dysplasia: Leveraging clinical trial experience and real-world data

October 25, 2022

Jeffrey S. Barrett, Megan Cala Pane, Timothy Knab, William Roddy, Jack Beusmans, Eric Jordie, Kanwaljit Singh, Jonathan Michael Davis, Klaus Romero, Michael Padula, Bernard Thebaud, Mark Turner. Front. Pharmacol. 2022 October 12. doi: 10.3389/fphar.2022.988974

Download PDF

Download PDF

A physiologically-based pharmacokinetic modeling approach to support candidate and first in human dose selection for bamlanivimab

September 3, 2021

Tim Knab, Ahmed Elmokadem, Emmanuel Chigutsa, Eric Jordie, Matthew Riggs, Patricia Brown-Augsburger, Christopher Wiethoff, Ajay Nirula, Jenny Y Chien, Lisa O’Brien.  Poster presented at Population Approach Group Europe Annual Meeting; 2-3 and 6-7 September 2021.  Poster I-64.

Download PDF